Drug dose individualisation in special populations, particularly paediatrics and obesity. This involves the design, conduct, and analysis of clinical trial data using pharmacokinetic and pharmacodynamic modelling and simulation techniques, and the subsequent development and trial of individualised dosing guidelines.

The clinical application of my research has been in the area of anticoagulation and insulin dosing in diabetes.

My research interests also include clinical pharmacy education and pharmacists’ professional competency.